Astrazeneca Plc ADR (NQ: AZN )
78.05
-0.13
(-0.17%)
Streaming Delayed Price
Updated: 11:47 AM EDT, Sep 27, 2024
Add to My Watchlist
All News about Astrazeneca Plc ADR
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
September 26, 2024
Via Benzinga
Exposures
Product Safety
AstraZeneca Options Trading: A Deep Dive into Market Sentiment
September 05, 2024
Via Benzinga
FLUMIST approved for self-administration in the US
September 20, 2024
From AstraZeneca
Via Business Wire
AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
September 18, 2024
Via Benzinga
Exposures
Product Safety
FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis
September 18, 2024
From AstraZeneca
Via Business Wire
AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
September 10, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.